Topical 2% Diltiazem for Anal Fissure
Topical 2% diltiazem cream should be applied as approximately 2 cm (0.7 g) to the anal verge twice daily for 8 weeks, and is an effective first-line pharmacological treatment for chronic anal fissure with fewer side effects than nitroglycerin. 1, 2
Compounding and Quality Concerns
Critical caveat: Compounded diltiazem formulations are frequently substandard. A quality analysis of 36 compounded 2% diltiazem preparations from retail pharmacies found that 36% were subpotent (34.8-89.8% of label claim), 14% were suprapotent (117-128% of label claim), and 39% lacked content uniformity 3. This means patients often receive ineffective or inconsistent doses despite correct prescribing. When possible, use a reputable compounding pharmacy with documented quality control, or consider alternative treatments if reliable compounding is unavailable.
The formulation should be a cream (not ointment), though some pharmacies incorrectly compound it as ointment 3. Specify "cream" explicitly on the prescription.
Application Protocol
- Dose: Apply approximately 2 cm (0.7 g) of 2% diltiazem cream
- Location: Directly to the anal verge
- Frequency: Twice daily
- Duration: 8 weeks initially 1, 2
- Timing: Can be applied on an empty stomach (though this is primarily relevant for oral formulations 4)
Expected Outcomes and Monitoring
Healing rates: 48-75% of chronic fissures heal after 8 weeks of treatment 1, 2. For patients who fail initial treatment, an additional 8-week course can achieve healing in approximately 50% of non-responders 2.
Monitor at 2-week intervals for:
- Pain relief (typically improves before complete healing)
- Bleeding reduction
- Fissure healing on examination
- Side effects (rare but include perianal dermatitis and headaches) 2
Recurrence: Approximately 34% of healed fissures recur within 6-12 months, but most respond to repeat treatment 2.
Contraindications (Systemic Absorption Considerations)
While topical application results in minimal systemic absorption, absolute contraindications from the FDA label include 4:
- Sick sinus syndrome (without functioning pacemaker)
- Second or third-degree AV block (without functioning pacemaker)
- Hypotension (<90 mmHg systolic)
- Acute myocardial infarction with pulmonary congestion
- Known hypersensitivity to diltiazem
Use with caution in patients with 4:
- Impaired hepatic or renal function (diltiazem is extensively metabolized by liver)
- Severe gastrointestinal narrowing
- Concurrent use of beta-blockers, digoxin, or other cardiac medications (potential additive effects on cardiac conduction)
Comparative Efficacy
Diltiazem is superior to glyceryl trinitrate (GTN) in several respects 5, 6:
- Better pain relief
- Fewer side effects (GTN causes headaches in up to 30% of patients)
- Lower recurrence rates
- Similar healing rates (48-75% vs 25-50% for GTN)
The most recent network meta-analysis (2025) found nifedipine has the highest healing rate, but diltiazem has the best pain reduction and lowest recurrence rate 6. Given diltiazem's excellent safety profile and superior analgesic properties, it remains an excellent first-line choice, particularly for pain-sensitive patients.
Treatment Algorithm
- First-line: Conservative care (fiber, fluids, sitz baths) for acute fissures 7
- Second-line: Topical 2% diltiazem cream for 8 weeks if conservative care fails or for chronic fissures
- If partial response: Extend treatment for additional 8 weeks 2
- If complete failure: Consider botulinum toxin injection or lateral internal sphincterotomy 7
- If recurrence: Repeat course of diltiazem (usually effective) 2
Key Clinical Pearls
- Diltiazem works by reversibly decreasing resting anal sphincter pressure, improving mucosal blood flow without permanent sphincter damage 7
- Side effects are minimal (perianal dermatitis in <6%, rare headaches) 2
- Off-midline fissures mandate evaluation for Crohn's disease, HIV, tuberculosis, syphilis, or malignancy 7
- Avoid digital rectal examination in acute, painful fissures—diagnosis is made by visual inspection with buttock traction 7
- The AGA guidelines note that topical calcium channel blockers (including diltiazem) are "as effective as topical GTN but have fewer associated side effects" 7